Idogen AB announced that Anders Karlsson has been appointed new CEO for the company. He will take up his new position on August 19, 2019. Anders Karlsson has a broad experience from a range of pharma and medtech companies, including leading positions at Novartis and Olerup International. Most recently, Anders Karlsson served as CEO of Allenex AB where he managed the merger with CareDx Inc. In his previous positions, he has successfully re-positioned companies and negotiated global cooperation agreements.